Patents Assigned to Venaxis, Inc.
  • Activity of recombinant equine follicle stimulating hormone
    Patent number: 8835386
    Abstract: The present invention provides methods of producing biologically active recombinant eFSH analogs and methods of increasing reproduction in mammals, particularly equine, using recombinant eFSH analogs. Also provided are methods of producing biologically active single chain recombinant eFSH. The recombinant eFSH analogs of the present invention increase superovulation, follicular development, embryo development, and reproductive efficiency in horses, cattle and other ungulates.
    Type: Grant
    Filed: November 28, 2008
    Date of Patent: September 16, 2014
    Assignees: Venaxis, Inc., Washington University, The Regents of the University of California
    Inventors: Mark Colgin, Kory Niswender, Irving Boime, Janet Roser